IEQ Capital’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
IEQ Capital's TXG Position: Q3 2026 in Review
IEQ Capital reduced its 10x Genomics (TXG) stake by 26% in Q3 2026, selling an estimated $8.13M and leaving 387,484 shares worth $35M. The position accounts for 0.15% of the portfolio, ranked #128.
IEQ Capital first reported a position in TXG in Q3 2020 and has held it in 24 quarters since. 494 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- IEQ Capital held 387,484 shares of 10x Genomics worth $35M as of Q3 2026.
- IEQ Capital sold 138,906 10x Genomics shares in Q3 2026, an estimated $8.13M.
- 10x Genomics made up 0.15% of IEQ Capital's portfolio in Q3 2026, its #128 holding.
- IEQ Capital first reported a position in 10x Genomics in Q3 2020 and has held it in 24 quarters since.
- 494 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.